Phase 3 Breast Cancer Patients Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Completed
Phase 3
Mepitel Film for the prevention of skin ulceration caused by radiation therapy in breast cancer patients.
Acute side effects of radiation therapy for breast cancerBreast cancer patients treated with radiation
University of Otago80 enrolled1 locationACTRN12612000949886
Recruiting
Phase 2Phase 3
A Randomized Trial Compared the Efficacy and Safety of Combined Use of Indocyanine Green Fluorescence and Methylene Blue Dye Versus Methylene Blue Dye alone for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Sentinel Lymph Node Biopsy in Breast Cancer Patients
Peking University People's Hospital Breast Cancer Center100 enrolled1 locationACTRN12612000109808
Completed
Phase 3
A randomized phase III trial with dose-dense sequential chemotherapy with epirubicin/paclitaxel/Cyclophosphamide-Methotrexate-Fluorouracil (CMF) vs epirubicin/CMF/docetaxel or paclitaxel as adjuvant chemotherapy in high-risk patients with operable breast cancer.
High risk breast cancer patients
Hellenic Cooperative Oncology Group1,000 enrolled1 locationACTRN12610000151033
Terminated
Phase 3
Tamoxifen and Exemestane Trial Bone Substudy - A substudy to Amendment 2 of the IBCSG 25-02 / BIG 3-02: Tamoxifen and Exemestane Trial (ACTRN12605000418673) hereby referred to as TEXT-2, which evaluates the effects of exemestane plus Gonadotropin-releasing hormone (GnRH) analogue as adjuvant therapy for premenopausal women with endocrine responsive breast cancer
Effects of adjuvant endocrine therapies on bone mineral density in pre-menopausal breast cancer patients.
Breast Cancer Trials200 enrolled1 locationACTRN12609000532202
Terminated
Phase 3
Cognitive Function Substudy - A substudy to the SOFT trial (ACTRN12605000416695) which evaluates the cognitive function of premenopausal women with endocrine responsive breast cancer participating in SOFT.
Cognitive function in pre-menopausal breast cancer patients
Breast Cancer Trials357 enrolled1 locationACTRN12607000542493